← Open Payments lookup

IGNACIO VALDES: Open Payments

NPI 1760546360 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$65,830 in 247 payments from 19 companies in 2025. Trend: 2023 $13,379 · 2024 $20,861 · 2025 $65,830

Speaker / faculty: $51,766Consulting: $7,838Food & beverage: $4,937Travel & lodging: $1,289
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.49$25,609
Teva Pharmaceuticals USA, Inc.56$21,859
Otsuka America Pharmaceutical, Inc.40$16,275
E.R. Squibb & Sons, L.L.C.24$417
Alkermes, Inc.20$411
Vanda Pharmaceuticals Inc.15$321
Janssen Pharmaceuticals, Inc11$295
Lundbeck LLC8$159
Supernus Pharmaceuticals, Inc.5$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$68

Products named: INGREZZA, UZEDY, ABILIFY MAINTENA, REXULTI, COBENFY, ARISTADA, FANAPT, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.